Corpus ID: 21769227

Comparative Proteomics of Tumor and Paired Normal Breast Tissue Highlights Potential Biomarkers in Breast Cancer.

@article{DaCosta2015ComparativePO,
  title={Comparative Proteomics of Tumor and Paired Normal Breast Tissue Highlights Potential Biomarkers in Breast Cancer.},
  author={Gustavo G{\'o}es Da Costa and Talita Helen Bombardelli Gomig and Rodrigo Kaviski and Karla Santos Sousa and Caroline Kukolj and Rubens Silveira de Lima and C{\'i}cero de Andrade Urban and Iglenir Jo{\~a}o Cavalli and Enilze Maria de Souza Fonseca Ribeiro},
  journal={Cancer genomics \& proteomics},
  year={2015},
  volume={12 5},
  pages={
          251-61
        }
}
BACKGROUND/AIM Breast cancer is the most common type of cancer among women worldwide, and about 57,000 new cases are expected for the Brazilian population in 2015. Elucidation of protein expression and modification is essential for the biological understanding, early diagnosis and therapeutics of breast cancer. The main objectives of the study are comparison between the proteome of tumor and paired non-tumor breast cancer tissues, describing all identified proteins, highlighting the ones most… Expand
Proteomic Analysis of Primary Colon Cancer and Synchronous Solitary Liver Metastasis
TLDR
These differentially expressed proteins (DEPs) can potentially be used as biomarkers for the diagnosis of liver metastasis and they may provide a new strategy for developing anti-metastatic liver drugs in colon cancer patients. Expand
Early diagnosis of colorectal cancer via plasma proteomic analysis of CRC and advanced adenomatous polyp
TLDR
FGB and C4A can be considered as plasma potential biomarkers to early diagnosis of CRC patients and understanding the underlying procedures in tumorigenesis to demonstrate that plasma proteins can be less invasive markers for the detection of CRC. Expand
Lipidomics investigations into the tissue phospholipidomic landscape of invasive ductal carcinoma of the breast
The need of identifying alternative therapeutic targets for invasive ductal carcinoma (IDC) of the breast with high specificity and sensitivity for effective therapeutic intervention is crucial forExpand
P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas
TLDR
The data suggest that high expression of P4HB and PDIA3 plays an important role in gliomas progression, and could predict the survival outcome and therapeutic response of glioma patients. Expand
Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis
  • Y. Chen, Zhixian Hong, +9 authors Y. Lu
  • Medicine
  • Medical science monitor : international medical journal of experimental and clinical research
  • 2018
TLDR
TPM1 may serve as a useful biomarker for predicting tumor recurrence and prognosis in patients with ICC and multivariate analysis showed that TPM1 could be a potential biomarkers for predicting the recurrence of ICC. Expand
Pediatric Ependymoma: A Proteomics Perspective.
TLDR
Through the proposed nanoLC-MS/MS method, a large number of similarities regarding proteome content are revealed compared to other two pediatric brain tumor entities; astrocytomas and medulloblastomas. Expand
Graph-theoretical comparison of normal and tumor networks in identifying BRCA genes
TLDR
A framework for the comparative graph-theoretical analysis of networks integrating the relevant gene expression, mutations, and potein-protein interaction network data and shows that a betweenness-based measure differentiates BRCA genes across all normal versus tumor network pairs, than the rest of the popular centrality-based measures. Expand
Function of the macrophage-capping protein in colorectal carcinoma.
TLDR
CapG was overexpressed in CRC and was associated with tumor progression; therefore, it may be a useful prognostic biomarker and therapeutic target in CRC. Expand
Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments.
TLDR
It is suggested that with use of absolute quantitative ECM proteomics to characterize tissues of interest, it will be possible to reconstruct more relevant in vitro models to investigate tumor-ECM dynamics at higher resolution. Expand
MicroRNA and protein profiles in invasive versus non‐invasive oral tongue squamous cell carcinoma cells in vitro
TLDR
This study shows HSC‐3 specific miRNA and protein expression in invasion, and suggests that miR‐498 and miR-940 affect invasion in vitro, the process being more influenced by mir‐940 silencing in aggressive H SC‐3 cells than in the less invasive SCC‐15. Expand
...
1
2
...

References

SHOWING 1-10 OF 108 REFERENCES
Proteomic analysis of non-tumoral breast tissue.
Breast cancer is a complex and heterogeneous disease. In spite of the advances made in recent decades, a better understanding of the intrinsic mechanisms of this disease is crucial. The developmentExpand
Comparative proteome analysis of breast cancer and normal breast
TLDR
Two-dimensional gel electrophoresis combined with mass spectrometry was used to analyze changes in the proteome of infiltrating ductal carcinoma compared to normal breast tissue, and proteomics offers a powerful methodology to detect the proteins that show different expression patterns in breast cancer tissue and may provide an accurate molecular classification. Expand
Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
TLDR
Comparing the proteome profile of primary breast tumors against that of lymph node metastasis strengthens previous omics-based studies and support the validation of potential markers of tumor invasion and metastasis. Expand
Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non‐tumoral adjacent counterparts
TLDR
51 protein spots are identified, corresponding to 34 differentially expressed proteins, which may represent promising candidate biomarkers for molecular‐based diagnosis of breast cancer and for pattern discovery, and the relevance of these proteins as factors contributing to breast carcinogenesis is discussed. Expand
The Differential Expression of Aqueous Soluble Proteins in Breast Normal and Cancerous Tissues in Relation to Stage and Grade of Patients
TLDR
A significant relationship between the expression of the proteins with the stage or grade of IDC can be established, which increases the usefulness of these proteins as biomarkers for IDC. Expand
Comparative proteomic analysis of ductal breast carcinoma demonstrates an altered expression of chaperonins and cytoskeletal proteins.
TLDR
The proteins which the authors observed to exhibit an altered expression in infiltrating ductal breast carcinoma may be exploited as novel targets for therapeutic interventions or represent novel diagnostic/prognostic markers for the early detection of aggressive tumors, particularly those with multridrug-resistant phenotypes during the earlier stages of the disease. Expand
Proteomic analysis in human breast cancer: Identification of a characteristic protein expression profile of malignant breast epithelium
TLDR
A proteomic analysis of matched normal and malignant epithelia from invasive breast carcinomas leads to a better understanding of oncogenesis at an operational level and helps to characterize the malignant phenotype of individual tumors, and thereby to identify novel targets for antineoplastic therapy. Expand
Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.
TLDR
14 biomarkers whose combination detects breast cancer patients from non-cancer controls with a sensitivity of 89% and specificity of 67%. Expand
Quantitative proteomic profiling of matched normal and tumor breast tissues.
Proteomic analysis of breast cancer tissue has proven difficult due to its inherent histological complexity. This pilot study presents preliminary evidence for the ability to differentiate adenomaExpand
Proteomics of human breast ductal carcinoma in situ.
TLDR
Proteomic analysis of DCIS revealed differential expression patterns distinct from previous nucleic acid-based studies and identified new facets of the earliest stage of breast cancer progression. Expand
...
1
2
3
4
5
...